Prevail Innovative Wealth Advisors, LLC Cue Biopharma, Inc. Put Options Transaction History
Prevail Innovative Wealth Advisors, LLC
- $515 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CUE
# of Institutions
53Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.3 Million1.28% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.43MShares$2.16 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$504,4830.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$476,7430.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $22.3M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...